InvestorsHub Logo
Followers 158
Posts 7116
Boards Moderated 0
Alias Born 12/01/2010

Re: Oracle post# 47

Wednesday, 01/05/2022 2:57:40 PM

Wednesday, January 05, 2022 2:57:40 PM

Post# of 235
It's the "Rare Pediatric disease" designation which is key here. By getting this they will be awarded a PRV worth up to $300M which will fund all their research for other applications for this same drug, and others in their pipeline.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IMMX News